MeiraGTx Holdings (MGTX) Cash from Investing Activities (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Cash from Investing Activities of -$1.1 million for Q4 2025, down 99.09% on a QoQ basis from -$547000.0 in Q3 2025, and up 10.59% year-over-year from -$984708.2 in Q4 2024.
MeiraGTx Holdings (MGTX) Cash from Investing Activities (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Cash from Investing Activities history runs 9 years deep, the most recent figure standing at -$1.1 million for Q4 2025.
- Quarterly Cash from Investing Activities rose 10.59% year-over-year to -$1.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.1 million (down 117.49% YoY) and the FY2025 annual result came in at -$4.1 million, down 117.49% from the prior year.
- Cash from Investing Activities was -$1.1 million for Q4 2025 at MeiraGTx Holdings, down from -$547000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $51.2 million in Q4 2023 and bottomed at -$25.4 million in Q4 2021.
- A 5-year average of -$2.7 million and a median of -$4.3 million in 2023 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2021 — Cash from Investing Activities plunged 367.49% — and 2023, when it jumped 702.66%.
- MeiraGTx Holdings' Cash from Investing Activities stood at -$25.4 million in 2021, then surged by 66.53% to -$8.5 million in 2022, then soared by 702.66% to $51.2 million in 2023, then slumped by 102.38% to -$1.2 million in 2024, then increased by 10.59% to -$1.1 million in 2025.
- Business Quant data shows MGTX's Cash from Investing Activities at -$1.1 million in Q4 2025, -$547000.0 in Q3 2025, and -$761000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -45.51 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -431.90 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -428.90 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 172.62 Mn |
| 10 | MeiraGTx Holdings | 997.33 Mn | 931.40 Mn | - | -1.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.09 Mn |
| Dec 31, 2025 | -1.09 Mn |
| Sep 30, 2025 | -547,000.00 |
| Sep 30, 2025 | -547,000.00 |
| Jun 30, 2025 | -761,000.00 |
| Jun 30, 2025 | -761,000.00 |
| Mar 31, 2025 | -1.71 Mn |
| Mar 31, 2025 | -1.71 Mn |
| Dec 31, 2024 | -1.22 Mn |
| Dec 31, 2024 | -1.22 Mn |
| Sep 30, 2024 | -1.31 Mn |
| Sep 30, 2024 | -1.31 Mn |
| Jun 30, 2024 | -1.33 Mn |
| Jun 30, 2024 | -1.33 Mn |
| Mar 31, 2024 | 27.34 Mn |
| Mar 31, 2024 | 27.34 Mn |
| Dec 31, 2023 | 51.18 Mn |
| Dec 31, 2023 | 51.18 Mn |
| Sep 30, 2023 | -3.56 Mn |
| Sep 30, 2023 | -3.56 Mn |